Please provide your email address to receive an email when new articles are posted on . PCI was not cost-effective vs. optimal medical therapy alone in patients with CAD and HF. Intervention conferred ...
That’s the question at the heart of two perspectives published this week in Circulation: Cardiovascular Quality and Outcomes, with Rasha Al-Lamee, MBBS, PhD, and Christopher Rajkumar, MBBS (Imperial ...
As a stricter gatekeeper to nonculprit lesion intervention in people with acute myocardial infarction (MI) going for complete revascularization, fractional flow reserve (FFR) guidance was projected to ...
Please provide your email address to receive an email when new articles are posted on . For patients with vulnerable plaque but no flow-limiting stenosis, PCI provided better clinical outcomes than ...
People with a buildup of fatty atherosclerotic plaque in the heart's arteries considered at risk of rupturing were far less likely to suffer a serious cardiac event if they underwent percutaneous ...
In a recent study, ticagrelor was found to be noninferior to prasugrel for a composite of ischemic events including death, myocardial infarction, stroke, and major bleeding after a year in ...
An increase in the number of percutaneous coronary interventions does not appear to have resulted in reduced mortality rates, ...
Percutaneous coronary intervention (PCI) is frequently performed to reduce the symptoms of stable angina. Whether PCI relieves angina more than a placebo procedure in patients who are not receiving ...
The American College of Cardiology has recognized Medical Center Hospital for its demonstrated expertise and commitment in treating patients with chest pain. Medical Center Hospital was awarded Chest ...
SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Reflow Medical, Inc. announced that it has received FDA commercial clearance for its coraCatheters™, a complete line of state-of-the-art microcatheters ...
News-Medical.Net on MSN
Rising primary PCI rates do not correlate with lower heart attack mortality in Europe
An increase in the number of percutaneous coronary interventions does not appear to have resulted in reduced mortality rates, according to results presented today at the EAPCI Summit 2026. The summit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results